Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. - Wikidata - wikimedia - TriplyDB

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

http://www.wikidata.org/entity/Q34075406

about

uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180.Organization, evolution and functions of the human and mouse Ly6/uPAR family genes Unique features of the transcriptional response to model aneuploidy in human cells The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma.MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis Discovery and analysis of pancreatic adenocarcinoma genes using cDNA microarrays.Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma Insights into endometrial serous carcinogenesis and progression.Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin.Involvement of urokinase-type plasminogen activator system in cancer: an overview.Sequences within domain II of the urokinase receptor critical for differential ligand recognition.Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling.Accelerated urokinase-receptor protein turnover triggered by interference with the addition of the glycolipid anchor.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.

P2860

Q24642555-9DFC919D-8BC3-49CB-941D-97416FD901C0 Q28071700-D4B69009-AC68-4355-A896-F57A5382F2FC Q28396449-1AFDFD28-8C66-4E3C-8DB4-92B132317707 Q33199829-52AFB8D4-CB58-4A30-85C7-55F6324001CE Q34731304-7666B238-DDD0-48AC-A77F-83BCFE3AF6E2 Q34737810-87866B1A-1F9F-4197-83AF-CE30CF45302F Q34776859-3E0059A4-89EC-4792-A894-21D13978C1A0 Q35166017-3EFB7044-9C9D-4B0C-B8F8-C8DCEB38DE13 Q35990029-F1531129-2043-48BB-AAC9-3D1F7B67E0C4 Q36059078-D101D8CD-A150-4808-9135-79046BC12D28 Q36616750-40ECBD4C-B1B7-4667-8E12-23AB4103F50B Q36642442-2D0CEA75-E6CF-41D6-8E44-E21F4F5DF516 Q37113899-5B8FD059-D0DE-4FDA-AB6B-DEA5979E2E81 Q37127024-BE7462BE-9250-4C92-8FE1-FF528C0D49FB Q37293935-B2B1161C-9D04-42EC-A663-4A415B283D44 Q38189275-469CEFF7-01CE-4612-B93D-A92A7E708BC5 Q38354388-19E70ED8-5EE8-4B39-B7A5-AFA853AB43DF Q39794539-BF0414BA-DA4C-4DEC-A085-E1351B2BB868 Q39842498-D8D3C48B-C718-4B1C-9A43-CDA778F87024 Q40492056-E9EC13B8-D7B8-4A88-8488-DBD27DE04717 Q44456291-733606C0-856D-45BC-B13D-CEB24615294D Q50531908-6B9A84D3-2078-4EBD-8A63-6D00AC98BC6B Q54960825-4FE5B0A7-CD9A-42B8-9D4F-860FF3058BA1

P2860

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

http://www.wikidata.org/entity/Q34075406

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@ast

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@en

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@nl

type

label

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@ast

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@en

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@nl

prefLabel

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@ast

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@en

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@nl

P1433

Q34075406-D81424FF-9238-47A8-8CC7-76974BB1A8B9

P1476

Q34075406-500A2AF9-D035-40E2-9CCE-13348F5905B7

P2093

Q34075406-3BCAE7D2-4553-4999-ABA2-6762CE698111

Q34075406-9D231377-BD47-4732-8126-C6DD48FFB04D

Q34075406-A2A797C4-C0A1-44D2-A08C-0B6AD7A32FE5

Q34075406-B1167F7A-56F3-411E-BAA4-5909E9395E01

Q34075406-D68BD99C-A0C1-4092-B6E2-7684B2F60440

Q34075406-DC0D058B-FC01-444D-899A-44C65CF33C44

P2860

Q34075406-0726905F-0DBA-4BFD-A7B0-868DDDE1F2DA

Q34075406-16F42D49-738D-459B-A3EF-594D226D3BDF

Q34075406-2D5BBBB3-54E1-4F56-85B7-CD86C420A6B3

Q34075406-3C5D2F7C-71C9-49C6-966C-1B734CF0A5EF

Q34075406-3D17A59A-C070-4E1D-891F-D4B8AE60BF1E

Q34075406-59D99C3F-E432-4324-8550-902E8FA4E3CD

Q34075406-6531908C-BDCF-42CA-8D62-3598419B77D5

Q34075406-7B747402-6990-4966-87D8-20AB339D08E1

Q34075406-7C1D9B0C-B99A-4DFF-BBA3-32C9C05792F4

Q34075406-7D92EB61-C6A1-44A0-86A1-64C7DD33472E

P304

Q34075406-AD59FF1F-5E76-4739-AFEF-229D516608C1

P31

Q34075406-D336481F-C4EA-47B9-9573-B99180C39B37

P356

Q34075406-0A3E7509-CCDA-45EF-83C4-74E7BAC7E957

P407

Q34075406-583566DF-E0A7-4F92-8CCC-CDAEB335A024

P433

Q34075406-D4787E32-0ABD-4020-82AC-887D6C414091

P478

Q34075406-919123F6-1AB1-4841-B0C7-B2837CB5AD0D

P50

Q34075406-A338B995-6004-4D8F-A97F-18A5C6A59812

P577

Q34075406-804A8EDA-A9D7-4FE3-9994-982BC79F5ABA

P5875

Q34075406-9B0BC076-EDD1-4D88-B6C2-E600101DF73D

P698

Q34075406-951DEF1B-B5F9-4251-A6B5-29B9C6E5FED4

P921

Q34075406-4F7DDCD5-E9C4-488F-987F-A295CD5CA4E3

P932

Q34075406-C3AFE996-DB33-4AAF-9C6E-3D0B4E8D21C4

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.

@en

P2093

Katherine R Kozak

http://www.w3.org/2001/XMLSchema#string

Lisbeth Chang

http://www.w3.org/2001/XMLSchema#string

Peter Shintaku

http://www.w3.org/2001/XMLSchema#string

Sanaz Memarzadeh

http://www.w3.org/2001/XMLSchema#string

Sathima Natarajan

http://www.w3.org/2001/XMLSchema#string

Srinivasa T Reddy

http://www.w3.org/2001/XMLSchema#string

P2860

K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma

MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.

Cancer statistics, 2000.

The urokinase receptor is required for human monocyte chemotaxis in vitro.

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.

P304

10647-10652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.152127499

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Robin Farias-Eisner

P577

2002-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11250345

http://www.w3.org/2001/XMLSchema#string

P698

12130664

http://www.w3.org/2001/XMLSchema#string

P921

P932

125001

http://www.w3.org/2001/XMLSchema#string